心房顫動市場：按程序（藥理學、非藥理學）、技術、最終用戶（醫院、專家、診所、其他）、地區 - 規模、份額、展望、機會分析，2022-2030 年

心房顫動是一種心律失常，其特徵是心臟電氣系統紊亂引起的異常心跳。房顫被認為是最常見的心律失常之一。緩慢、快速或不規則的心跳稱為心律失常。未經治療的房顫可導致中風和其他嚴重並發症。如果您患有糖尿病、高血壓或其他心髒病，房顫可能很危險。

心房顫動可以作為單次發作或慢性疾病、心律不齊、心律失常、虛弱、頭暈、疲勞和其他症狀發生。心房顫動通常是由混亂的信號引起的，這些信號會導致心臟的兩個頂部腔室，即心房，快速而不合時宜地收縮。由於心房收縮如此之快，心壁顫動。心房顫動可由心臟電系統受損引起。在心房顫動中，心臟上腔的信號被破壞。結果，上心室顫動。然後，房室結試圖到達下心室，衝動衝入（心室）。這會導致快速、不規則的心跳。

市場動態

酒精的大量消費預計也有助於市場增長。例如，根據 2021 年 8 月發布的數據，美國分析和諮詢公司蓋洛普表示，到 2021 年，約 60% 的美國成年人將飲用酒精飲料。

這項研究的主要特點

• 本報告對全球心房顫動市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2030 年）內市場規模和復合年增長率 (CAGR%) 的增長。
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供重要見解，包括市場驅動因素、制約因素、機會、新產品發布和批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
• 根據公司亮點、產品組合、主要亮點、績效和戰略等參數介紹全球心房顫動市場主要參與者的概況。
• 本研究涵蓋的主要公司包括 AtriCure, Inc.、Biosense Webster, Inc.、Boehringer Ingelheim GmbH、波士頓科學公司、Bristol-Myers Squibb Corporation、CardioFocus, Inc.、Endoscopic Technologies, Inc.、Sanofi Aventis 、強生有限公司和雅培實驗室。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 《全球心房顫動市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球心房顫動市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按程序
  • 市場概況：按技術分類
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 技術概覽
• 監管情景
• 管道分析
• 害蟲分析

第 4 章全球心房顫動市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球心房顫動市場：按程序，2017-2030

• 藥理學
• 通過藥理學方法
• 非藥物性

第 6 章全球心房顫動市場：按技術分類，2017-2030

• 無線電波
• 激光
• 冷凍療法
• 其他

第 7 章全球心房顫動市場：按最終用戶分類，2017-2030

• 醫院
• 專科診所
• 其他

第 8 章全球房顫市場：地區，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• AtriCure, Inc, Inc
• Biosense Webster
• Boehringer Ingelheim GmbH
• Boston Scientific Corporation
• Bristol-Myers Squibb Corporation
• CardioFocus, Inc.
• Endoscopic Technologies, Inc
• Sanofi Aventis
• Johnson and Johnson Ltd.
• Abbott Laboratories
• Research Methodology
• About Us

Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. It is considered to be one of the most prevalent types of cardiac arrhythmia. When the heart beats too slowly, too quickly, or irregularly, it is called an arrhythmia. Atrial fibrillation if untreated, can lead to a stroke and other serious medical complications. Atrial fibrillation can be dangerous if a person have diabetes, high blood pressure or other diseases of the heart.

Atrial fibrillation may occur in isolated incidents or it may be a chronic illness, fluttering heartbeat, irregular pulse, weakness, dizziness, and fatigue. Atrial fibrillation is mostly brought on by chaotic signals that cause the atria, the two top chambers of your heart, to contract quickly and out of time. Because of how swiftly they contract, the heart's walls fibrillate. Atrial fibrillation may result from electrical system damage to your heart. The signals in the upper chambers of the heart are disorganized in atrial fibrillation. The outcome is a shaking of the higher chambers (quiver). The lower cardiac chambers are then attempted to be reached by the AV node, which is then inundated with impulses (ventricles). A quick and erratic heart rhythm results from this.

Market Dynamics

High consumption of alcohol is also expected to aid in growth of the market. For instance, according to data published on August 2021, on Gallup, Inc, which is an U.S. analytics and advisory company, stated that about 60% of U.S. adults drink alcoholic beverages in 2021.

Key features of the study:

• This report provides an in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd., and Abbott Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market

Detailed Segmentation:

• Global Atrial Fibrillation Market, By Procedure:
  • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
• Global Atrial Fibrillation Market, By Technology:
  • Radiofrequency
  • Laser
  • Cryotherapy
  • Others
• Global Atrial Fibrillation Market, By End User:
  • Hospitals
  • Speciality Clinics
  • Others
• Global Atrial Fibrillation Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • AtriCure, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biosense Webster, Inc
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis
  • Johnson and Johnson Ltd
  • Abbott Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Procedure
  • Market Snapshot, By Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pipeline Analysis
• PEST Analysis

4. Global Atrial Fibrillation Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Atrial Fibrillation Market, By Procedure, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pharmacological
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• By Pharmacological
  • Anti-arrhythmic
  • Anti-coagulant
• Non-Pharmacological
  • Catheter Ablation Procedures,
  • Maze surgery,
  • Electric Cardioversion

6. Global Atrial Fibrillation Market, By Technology, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Radiofrequency
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Laser
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cryotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Atrial Fibrillation Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Specialty clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Atrial Fibrillation Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• AtriCure, Inc, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biosense Webster
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bristol-Myers Squibb Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CardioFocus, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Endoscopic Technologies, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi Aventis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson and Johnson Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Research Methodology
• About Us